Clinical trial
Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or…
NCT00020007 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00020007 |
|---|---|
| Title | Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery |
| Official title | A Phase I Study of Isolated Lung Perfusion With Paclitaxel and Moderate Hyperthermia in Patients With Unresectable Pulmonary Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer, Metastatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | isolated perfusion, paclitaxel, hyperthermia treatment |
| Start date | Dec 1, 1999 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 29, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: